IL1B and diabetic retinopathy: The accumulated oxidized lipofuscin components serve as damage-associated molecular patterns, activating complement pathways through C3 and factor H, triggering sustained inflammatory cytokine release (IL-1β, TNF-α, IL-6) that creates a chronic pro-inflammatory microenvironment characteristic of diabetic retinopathy progression [34].